******HOT STOCK ON THE WATCHLIST FOR A SWING TRADE IN THE WEEKS TO COME, SPECULATION AND RUMORS HAVE BROUGHT IT THE ATTENTION OF MANY AND SOME ACCUMULATION HAS STARTED TO TAKE PLACE. JUST LIKE MOST BIO STOCKS, AMEX:OGEN TENDS TO MOVE VERY FAST FOR GREAT GAINS ON TRIAL AND DATA RELEASE, SO SET YOUR ALERTS FOR SPIKES.
AVERAGE ANALYSTS PRICE TARGET $2.50 AVERAGE ANALYSTS RECOMMENDATION BUY
COMPANY PROFILE Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.